SPONSOR
Sunshine Lake Pharma Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
NCT05451602 Phase 1, Phase 2
Recruiting
HEC169096 in Participants With Advanced Solid Tumors
Advanced Solid Tumor
NCT05133882 Phase 1, Phase 2
Recruiting
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Acute Myeloid Leukemia, Adult